CipherOx CRI Tablet— 510(k) K213255

Substantially Equivalent

Flashback Technologies, Inc.

FDA 510(k) clearance K213255 for CipherOx CRI Tablet, Substantially Equivalent on 2022-06-17. Applicant: Flashback Technologies, Inc..

Clearance details

Applicant: Flashback Technologies, Inc.
Product code: Code PPW
Advisory panel: Cardiovascular
Date received: 2021-09-30
Decision date: 2022-06-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westfield, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.